UPTAKE IN VIVO AND IN VITRO OF ACTINOMYCIN D BY MOUSE LEUKEMIAS AS FACTORS IN SURVIVAL

被引:47
作者
KESSEL, D
WODINSKY, I
机构
[1] Children's Cancer Research Foundation, Boston
[2] Arthur D. Little, Inc., Cambridge, MA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/0006-2952(68)90170-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:161 / &
相关论文
共 30 条
[1]  
BURCHENAL JH, 1963, CANCER RES, V23, P1364
[2]  
BURCHENAL JH, 1962, CANCER CHEMOTHERAPY, V19, P19
[3]  
CIFFERA O, 1965, BIOCHEM J, V59, P853
[4]  
DAVIDSON JN, 1964, PROGRESS NUCLEIC ED, V3, P183
[5]   INCORPORATION OF TRITIATED ACTINOMYCIN D INTO DRUG-SENSITIVE AND DRUG-RESISTANT HELA CELLS [J].
GOLDSTEIN, MN ;
HAMM, K ;
AMROD, E .
SCIENCE, 1966, 151 (3717) :1555-+
[6]   X-RAY DIFFRACTION AND MOLECULAR MODEL BUILDING STUDIES OF INTERACTION OF ACTINOMYCIN WITH NUCLEIC ACIDS [J].
HAMILTON, LD ;
FULLER, W ;
REICH, E .
NATURE, 1963, 198 (488) :538-&
[7]  
HARBERS E, 1963, BIOCHEM Z, V337, P224
[8]   INHIBITION OF PROTEIN SYNTHESIS IN E COLI PROTOPLASTS BY ACTINOMYCIN-D [J].
HAYWOOD, AM ;
SINSHEIMER, RL .
JOURNAL OF MOLECULAR BIOLOGY, 1963, 6 (03) :247-&
[9]   ACTINOMYCIN D - INHIBITION OF PROTEIN SYNTHESIS UNRELATED TO EFFECT ON TEMPLATE RNA SYNTHESIS [J].
HONIG, GR ;
RABINOVITZ, M .
SCIENCE, 1965, 149 (3691) :1504-+
[10]  
KATZ E, 1965, J MOL PHARMACOL, V1, P107